This author has not written his bio yet.
But we are proud to say that Thomas Gabrielczyk contributed 1379 entries already.
Renewed focus on cancer: COVID-19 vaccine company BioNTech SE (Nasdaq: BNTX) and Ryvu Therapeutics S.A., located in Krakow (Warsaw Stock Exchange: RVU), a Polish clinical-stage cancer therapeutics development company, announced […]
AstraZeneca announced an agreement to acquire Neogene Therapeutics Inc. (Neogene), a global clinical-stage biotechnology company spezialised in next-generation T-cell receptor therapies (TCR-Ts) that offer a novel cell therapy approach for […]
London-based computer vision specialist V7 Ltd has baged $33m in Series A financing co-led by AI-focused Radical Ventures and Temasek.
Latest investment trends were presented by BIOTECH Insight at the start of the German Equity Forum
C4X Discovery Holdings plc has exclusively licenced its NRF2 Activator programme to AstraZeneca and has got an upfront payment of $2m.
EpiEndo Pharmaceuticals ehf got the green light for a Phase IIa COPD trial with its non-anbibiotic macrolide EP395
German Neotiv GmbH hat closed a 10m seed financing to speed-up product launch of its early diagnosis app for Alzheimer’s disease
Researchers from the University of Linz (Austria) report progress on the way to make electronic devices more sustainable and more recyclable
Antibody developer Memo Therapeutics AG has snaged a R&D partnership with Ono Pharmaceutical Co. Ltd in the immuno-oncology field.
The European Council has adopted three regulations aimed at improving pandemic preparedness, which together with two other pillars complete the EU Health Union.